CPB trades 2.3% above Wall Street's consensus target of $20.67.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CPB achieves its forward estimates and maintains a stable P/E multiple of 9.7x. This scenario reflects the blended consensus of 29 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 21, 2026, Campbell Soup Company (CPB) has a Wall Street consensus price target of $20.67, based on estimates from 29 covering analysts. With the stock currently trading at $21.15, this represents a potential downside of -2.3%. The company has a market capitalization of $6.31B.
Analyst price targets range from a low of $17.00 to a high of $28.00, representing a 53% spread in expectations. The median target of $20.00 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Hold, with 1 analysts rating the stock as a Buy or Strong Buy,17 rating it Hold, and 11 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, CPB trades at a trailing P/E of 10.5x and forward P/E of 9.7x. Analysts expect EPS to grow +6.9% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $24.55, with bear and bull scenarios of $15.47 and $32.35 respectively. Model confidence stands at 55/100, reflecting moderate uncertainty in projections.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
GISGeneral Mills, Inc. | $17.8B | $33.42 | $37.30 | +11.6% | Hold | 9.8x | 34 |
KKellanova | $29.0B | $83.44 | $74.03 | -11.3% | Hold | 22.1x | 34 |
HRLHormel Foods Corporation | $13.3B | $24.16 | $23.50 | -2.7% | Hold | 16.3x | 29 |
SJMThe J. M. Smucker Company | $11.8B | $110.86 | $120.33 | +8.5% | Buy | 12.3x | 31 |
CAGConagra Brands, Inc. | $6.3B | $13.20 | $15.20 | +15.2% | Hold | 7.8x | 25 |
MKCMcCormick & Company, Incorporated | $11.8B | $46.64 | $68.75 | +47.4% | Hold | 15.1x | 30 |
KHCThe Kraft Heinz Company | $27.1B | $22.82 | $22.60 | -1.0% | Hold | 11.1x | 35 |
MDLZMondelez International, Inc. | $77.2B | $60.12 | $67.00 | +11.4% | Buy | 19.7x | 41 |
HSYThe Hershey Company | $35.0B | $172.63 | $224.23 | +29.9% | Hold | 20.4x | 35 |
POSTPost Holdings, Inc. | $4.0B | $88.41 | $114.50 | +29.5% | Buy | 11.5x | 19 |
Quick answers to the most common questions about buying CPB stock.
Wall Street's consensus price target for CPB is $20.67, -2.3% from its current price of $21.15. The below-market target from 29 analysts suggests limited near-term appreciation.
CPB has a consensus rating of "Hold" based on 29 Wall Street analysts. The rating breakdown is leaning bearish, with 11 Sell/Strong Sell ratings. The consensus 12-month price target of $20.67 implies -2.3% downside from current levels.
With a forward P/E of 9.7308x, CPB trades at a relatively low valuation. The consensus target of $20.67 implies -2.3% move, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $28 for CPB, while the most conservative target is $17. The consensus of $20.67 represents the median expectation. Our quantitative valuation model projects a bull case target of $32 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CPB is heavily covered by Wall Street, with 29 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 17 recommend Hold, and 11 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CPB stock forecast based on 29 Wall Street analysts shows a consensus price target of $20.67, with estimates ranging from $17 (bear case) to $28 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $25, with bear/bull scenarios of $15/$32.
Our quantitative valuation model calculates CPB's fair value at $25 (base case), with a bear case of $15 and bull case of $32. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 55/100.
CPB trades at a forward P/E ratio of 9.7x based on next-twelve-months earnings estimates compared to a trailing P/E of 10.5x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on CPB, with 11 Sell ratings and a price target of $20.67 (-2.3% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CPB analyst price targets range from $17 to $28, a 53% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $20.67 consensus represents the middle ground. Our model's $15-$32 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.